Skip to main content
. Author manuscript; available in PMC: 2017 May 15.
Published in final edited form as: IEEE Sens J. 2015 May 5;16(10):3349–3366. doi: 10.1109/JSEN.2015.2429738

Fig. 2.

Fig. 2

(a) Structure of NIH-1 and two inactive variants 1b and 1g. Observed LWV shift from the binding of 50 µM (b) NHI-1, 1b and 1g to immobilized hLDH-A, (c) SM-164 to immobilized GST-XIAP, (d) dorzolamide to immobilized CA-II, (e) dicoumarol to immobilized NQO1, and (f) Q-VD-OPh to immobilized caspase-3. Dashed line represents the time at which small molecule was added to the active well. Self-referencing was applied to each. Reprinted with permission from [82], © 2014 American Chemical Society.